Introducing the Hadassah Accelerator 2025 Cohort: The Future of HealthTech is Here

‍

Shaping the Future of Healthcare Innovation

The 2025 cohort spans critical areas of healthcare transformation—from surgical precision and sleep diagnostics to neonatal monitoring and therapeutic nutrition. Each company was selected for their potential to transform patient outcomes through validated science, intelligent software, and deep clinical integration.

These five innovative startups will leverage Hadassah Medical Center's unique ecosystem, combining access to real-world hospital data, clinical expertise, and world-class research facilities to accelerate their path from concept to clinic.

Meet Our 2025 Cohort

SurgiAI - Guiding Every Surgical Step

AI for Surgical Precision

SurgiAI is addressing a critical unmet need in surgery with AI-powered guidance that adapts to real-time tissue shifts. Their innovative technology focuses on reducing procedure time and improving outcomes in complex soft tissue procedures by providing surgeons with intelligent, adaptive guidance throughout surgical operations. The company represents the cutting edge of AI for surgical precision, offering solutions that enhance surgical accuracy and efficiency.

anydish - Nutrition as Treatment

anydish is an AI-powered personalized nutrition platform that transforms complex clinical needs and patient culinary preferences into practical, tailored meal choices. The platform provides health practitioners with efficient tools while empowering patients with a variety of delicious, relevant recipes they can trust. By making food an integral part of medical treatment, anydish bridges the gap between clinical nutrition requirements and patient preferences, revolutionizing how nutrition is integrated into healthcare.

Bilieye - Non-Invasive Neonatal Monitoring

Bilieye is a med-tech startup developing a non-invasive software solution to monitor jaundice in newborns using a smartphone-based app. Their innovative technology enables early detection and continuous monitoring of bilirubin levels, aiming to improve newborn care and reduce the need for invasive blood tests. The company's solution represents a significant advancement in neonatal healthcare, making critical monitoring more accessible and less stressful for both babies and parents.

SleepAI - Reimagining Sleep Apnea Diagnostics

Healthcare Intelligence

SleepAI transforms any oximetry-based device into a high-precision diagnostic tool for sleep apnea diagnostics. Validated across six datasets and peer-reviewed studies, the company offers scalable, cost-effective, multi-night monitoring that brings lab-grade sleep analysis to the home. Their healthcare intelligence platform reimagines sleep medicine by making professional-grade sleep diagnostics more accessible and convenient for patients while maintaining clinical accuracy.

Plectrum - Revolutionizing Digital Touch

Plectrum transforms how we connect by enabling real-time, remote tactile communication through proprietary smart textiles. Their wearable interface brings touch into digital spaces, supporting sensory therapy, immersive VR, and emotional connection from afar. The company is revolutionizing digital touch technology, creating new possibilities for remote communication and interaction that go beyond traditional visual and audio connections.

Why This Cohort Matters

The 2025 cohort represents a comprehensive approach to healthcare innovation:

Surgical Excellence: Advanced AI guidance systems that enhance surgical precision and reduce procedure complexity.

Preventive Care: Non-invasive monitoring solutions that catch health issues early and reduce the need for invasive procedures.

Personalized Medicine: AI-driven platforms that tailor treatments and interventions to individual patient needs.

Accessible Healthcare: Technologies that bring hospital-grade diagnostics and monitoring to patients' homes.

Human Connection: Innovations that maintain and enhance human touch and emotional connection in an increasingly digital healthcare landscape.

The Hadassah Advantage

These startups will benefit from Hadassah Medical Center's unparalleled resources:

• Real-World Validation: Access to two multidisciplinary hospital facilities with 1,400 patient beds
• Rich Data Environment: Over 40 years of digital health data for research and AI model training
• Clinical Expertise: Direct collaboration with leading medical professionals and researchers
• Proven Track Record: Following 34 graduate startups that have collectively raised over $90 million

Looking Forward

The 2025 cohort represents more than just innovative technology—they embody a vision of healthcare that is more precise, accessible, and human-centered. As they begin their journey in the Hadassah Accelerator program, these companies will work closely with clinical teams to validate their solutions, refine their technologies, and prepare for global market deployment.

We're excited to support this extraordinary group of founders as they bring life-changing technologies from concept to clinic. Their work today will define the future of healthcare delivery, making it more effective, efficient, and accessible for patients worldwide.

The Hadassah Accelerator, powered by IBM Alpha Zone, continues to be the premier destination for healthcare startups seeking to make a meaningful impact. Applications for future cohorts open annually, bringing together the brightest minds in healthcare innovation.

‍